Fig. 1
From: 5α-reductase inhibitors impact prognosis of urothelial carcinoma
Kaplan-Meier estimate of Bladder Cancer related mortality in patients who received 5α-reductase inhibitor and nonuser
Fig. 1 | BMC Cancer
From: 5α-reductase inhibitors impact prognosis of urothelial carcinoma
Kaplan-Meier estimate of Bladder Cancer related mortality in patients who received 5α-reductase inhibitor and nonuser